Clinical evaluation of a new theophylline derivative in the treatment of psychiatric patients.
D000328:Adult; D001714:Bipolar Disorder / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects; D002389:Catatonia / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002746:Chlorpromazine / Q000627:therapeutic use; D004155:Diphenhydramine / Q000627:therapeutic use; D004342:Drug Hypersensitivity; D004569:Electroencephalography; D005260:Female; D006801:Humans; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy*; D012640:Seizures / Q000139:chemically induced*; D013806:Theophylline / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014202:Tremor / Q000139:chemically induced
D000697:Central Nervous System Stimulants; D004155:Diphenhydramine; D013806:Theophylline; D002746:Chlorpromazine